These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3234464)

  • 1. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S; Longo A; Toon S; Rolan P; Evans AM
    Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of L-carnitine.
    Evans AM; Fornasini G
    Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
    Rebouche CJ
    Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose.
    Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
    J Pharm Sci; 1995 May; 84(5):634-9. PubMed ID: 7658357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.
    Cao Y; Wang YX; Liu CJ; Wang LX; Han ZW; Wang CB
    Clin Invest Med; 2009 Feb; 32(1):E13-9. PubMed ID: 19178874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
    Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
    Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of intravenously administered carnitine in haemodialysed children.
    Glöggler A; Bulla M; Fürst P
    J Pharm Biomed Anal; 1990; 8(5):411-4. PubMed ID: 2081201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolite kinetics of oral L-carnitine in humans.
    Bain MA; Milne RW; Evans AM
    J Clin Pharmacol; 2006 Oct; 46(10):1163-70. PubMed ID: 16988205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of omeprazole in humans--a study of single intravenous and oral doses.
    Regårdh CG; Andersson T; Lagerström PO; Lundborg P; Skånberg I
    Ther Drug Monit; 1990 Mar; 12(2):163-72. PubMed ID: 2315973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
    Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
    Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S
    Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profile of fosfomycin trometamol.
    Bergan T; Thorsteinsson SB; Albini E
    Chemotherapy; 1993; 39(5):297-301. PubMed ID: 8370321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of bambuterol in healthy subjects.
    Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
    Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yohimbine bioavailability in humans.
    Guthrie SK; Hariharan M; Grunhaus LJ
    Eur J Clin Pharmacol; 1990; 39(4):409-11. PubMed ID: 2076728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.